Core Insights - The announcement of Innovent Biologics being included in the Hang Seng Index marks a significant milestone, as it becomes the first Chinese innovative pharmaceutical company to transition from Biotech to Biopharma under the Hong Kong Stock Exchange's 18A system [1] - This achievement aligns with the company's recognition as "Annual High-Quality Development Listed Company" in the 2025 New Consumption and New Economy Awards [3] Group 1: Market Position and Financial Performance - Innovent Biologics has transitioned from a story-driven early biotech firm to a stable investment asset, supported by 18 commercialized innovative drugs and a complete industry chain from R&D to production [4] - The company's revenue has surged from 1 billion yuan in 2019 to 9.4 billion yuan in 2024, representing an 840% increase over five years, with expectations to exceed 10 billion yuan in 2025 [4] - The inclusion in the Hang Seng Index is expected to attract billions of dollars in passive capital inflow, optimizing the investor structure and reducing stock price volatility [4] Group 2: Product Development and Innovation - Innovent's mature products, such as Sintilimab, continue to provide stable cash flow, while new products like MaShidu Peptide strengthen its market position in the weight management sector [5] - The company has achieved significant milestones in R&D, with its MaShidu Peptide being the first globally approved dual-target receptor agonist for GCG/GLP-1, addressing specific health issues in Chinese patients [6] - Innovent's innovative capabilities are further demonstrated by its IL-23p19 monoclonal antibody showing strong efficacy in clinical trials for psoriasis, and the introduction of China's first IGF-1R antibody for thyroid eye disease [6] Group 3: Globalization and Strategic Partnerships - Innovent's globalization strategy has evolved from licensing to co-development, exemplified by a landmark $11.4 billion global strategic partnership with Takeda Pharmaceuticals [7] - The partnership adopts a "Co-Co" model, allowing Innovent to participate deeply in global clinical design and commercialization processes, marking a shift from traditional licensing agreements [7] - This collaboration signifies a critical step for Chinese pharmaceutical companies to engage in high-standard international platforms, enhancing their global competitiveness [8] Group 4: Overall Impact and Future Outlook - Innovent Biologics' journey from a local lab to a prominent player in the Hang Seng Index illustrates a successful model for the sustainable development of China's biopharmaceutical industry [9] - The company's integrated approach of capital, product strength, and globalization serves as a promising template for future growth and stability in the sector [9]

【#众泰汽车董事长上任两个月后辞职#】12月29日，众泰汽车公告，公司董事长李立忠因个人家庭原因 申请辞去董事长、董事职务，同时辞去董事会战略委员会主任委员、提名委员会委员职务。李立忠的辞 职不会导致公司董事会成员低于法定最低人数，不会影响公司董事会的正常运行，亦不会对公司的日常 经营产生不利影响，辞职报告自送达董事会之日起生效。此外，公司董事会提名韩必文为第九届董事会 非独立董事候选人，任期自股东会审议通过之日起至第九届董事会届满之日止。 此前10月30日，众泰汽车新董事会正式履职，李立忠任董事长。直到此次离职，李立忠担任众泰汽车董 事长仅两个月时间。 12 月 29 目, 公司董事长李立忠因个人家庭原因申请辞去董 事长、董事职务,同时辞去董事会战略委员会 主任委员、提名委员会委员职务。李立忠的辞 职不会导致公司董事会成员低于法定最低人 数,不会影响公司董事会的正常运行,亦不会 对公司的日常经营产生不利影响，辞职报告自 送达董事会之日起生效。此外,公司董事会提 名韩必文为第九届董事会非独立董事候选人, 任期自股东会审议通过之日起至第九届董事会 届满之日止。 此前10月30日,众泰汽车新董事会正式履 职,李立 ...

近年来，医疗健康行业正加速探索大模型、智能体等AI前沿技术的创新应用。12月29日，北京大学人 民医院（以下简称"北大人民医院"）与蚂蚁健康联合组建的"医学人工智能创新联合研究中心"正式揭牌 成立，旨在共同推动人工智能技术在医疗健康领域的前沿研究和应用落地。 同期，由北大人民医院牵头，联合中国信息通信研究院（以下简称"中国信通院"）、蚂蚁健康及多家顶 尖医院共同编制的全国首个外科领域 "AI医生" 标准正式面世，在医学AI的技术应用标准、规范上迈出 了系统化的关键一步。 北大人民医院院长、中国工程院院士王俊在揭牌仪式上表示，该研究中心将聚焦临床真实痛点，重点探 索AI在专病智能诊疗、临床决策支持及健康管理模型等方向的创新应用，全力推动将科研成果转化为 更普惠、更可及的医疗健康服务。 同时，由王俊院士等6名院士领衔，全国超500位医生已在"蚂蚁阿福"App上线了"名医AI分身"，为公众 提供7X24小时的专业健康咨询服务，让顶级专家的优秀经验更普惠地服务大众健康。 《2025年政府工作报告》明确提出加快开展"人工智能+医疗健康"工作，培育医疗健康行业新质生产 力。同年8月，国务院发布《关于深入实施"人工智能+" ...

2026年1月1日起，东航免费WiFi服务将扩大到所有宽体机执飞的国内航班。此前，东航免费WiFi服务 只覆盖空中快线，范围扩大后，东航所有宽体机执飞的国内航班(不含港澳台)头等舱和公务舱旅客可免 费畅享高速版空中WiFi，经济舱旅客可免费畅享标准版(焕新)空中WiFi。 (东方航空) ...

Group 1 - The core point of the article is that SMIC plans to acquire a 49% stake in SMIC North for 40.6 billion yuan, which will result in SMIC holding 100% of SMIC North after the transaction [1][2] - The acquisition is expected to enhance the asset quality of the listed company and improve business synergy, promoting long-term development [1] - The main business scope of the listed company will remain unchanged before and after the transaction [1] Group 2 - SMIC also announced a new joint venture agreement and capital increase agreement with the National Integrated Circuit Fund and its second phase, increasing the registered capital of SMIC South from 6.5 billion USD to 10.0773 billion USD [2] - Various stakeholders will hold specific percentages of equity in SMIC South, including SMIC Holdings at 41.561%, National Integrated Circuit Fund at 9.392%, and others [2]

【#影视院线板块震荡反弹#，#百纳千成20cm涨停#】影视院线板块震荡反弹，百纳千成"20cm"涨停， 横店影视、金逸影视、博纳影业、上海电影、文投控股、幸福蓝海等跟涨。（界面） ...

"全球大模型第一股"即将登陆港股。北京智谱华章科技股份有限公司（下称"智谱"）今起招股，预计 2026年1月5日结束，并计划于2026年1月8日正式以"2513"为股票代码在港交所主板挂牌上市。 招股书显示，智谱云端MaaS和订阅业务呈现指数级增长趋势。在全球大模型超市 OpenRouter 上GLM- 4.5/4.6 自上线以来调用量稳居全球前10，付费 API 收入超过所有国产模型之和，API平台的企业和开发 者用户数超290万。截至目前，智谱GLM大模型已赋能了全球12000家企业客户、逾8000万台终端用户 设备及超4500万名开发者，是中国赋能终端设备最多的独立通用大模型厂商。 全球公开发售文件显示，智谱计划在本次IPO中发行【3741.95】万股H股。其中，香港公开发售 【187.1】万股H股，国际发售【3554.85】万股H股。以每股【116.20】港元发行价计算，智谱本次IPO 募资总额预计将达43亿港元，IPO市值预计超511亿港元。 云集一众知名投资机构 智谱作为中国最早研发大模型的企业，也是中国收入体量最大的独立大模型厂商，一直备受市场青睐， 在IPO之前，智谱已完成了8轮融资，融资规模 ...

12月29日，乘联分会秘书长崔东树发文称，2026年车市增长的原因比较复杂，其中重要因素之一，是春 节时间滞后叠加国家补贴实施较早，效果会较为突出，1月将实现车市开门红正增长。 2月虽压力较大，但1-2月仍将实现车市开门红。预计2026年第一季度车市有望同比持平，环比或下降 25%(前10年的平均降幅)。新能源汽车2026年第一季度有望同比微增5%，环比降36%(前10年的平均降 幅)。 ...

12月29日，国务院国资委党委书记、主任张玉卓在学习时报刊发文章《坚定不移做强做优做大国有企业 和国有资本》。 其中提到，加快传统产业转型升级，深化拓展"人工智能+"行动，通过设备改造、技术攻关、产品升 级、品牌建设等多种途径，进一步增加高端产品和服务供给，不断巩固提升我国传统优势产业在全球产 业分工中的地位和竞争力；更大力度布局发展新兴产业和未来产业，依托焕新、启航行动，接续发力新 能源、新能源汽车、新材料、低空经济等重点领域，当好发展实体经济的长期资本、耐心资本和战略资 本。 ...

Core Viewpoint - The company, Gujia Home, has clarified that all sofas sold during the live stream hosted by top influencer Dong Yuhui are produced in-house, addressing concerns about third-party manufacturing [1] Group 1: Sales Performance - Dong Yuhui's live stream on December 11 generated a record sales figure of 3.56 billion yuan, with a single Gujia Home sofa product exceeding 100 million yuan in sales, making it the top-selling item of the event [1] - The live stream lasted for five and a half hours, showcasing the significant impact of influencer marketing on sales performance in the home furnishings sector [1] Group 2: Production and Manufacturing - Gujia Home's representative stated that the company is accelerating production to meet demand, ensuring that the products sold during the live stream are self-manufactured [1] - The company's 2024 annual report indicates that outsourcing is only used to alleviate capacity pressure for non-core products, while core products such as sofas, soft beds, and custom furniture are designed and produced in-house [1]